Chronic urticaria is a skin disorder with a very high impact on patients' quality of life. It has a prevalence between 7,8 and 22,3% with a higher incidence in women between 20 and 40 years old. The intensity of the itch, the anxiety caused by its recurrent nature and also the ...
The exploration of novel therapeutic targets for their role and relevance in CSU should help to achieve a better understanding of its etiopathogenesis. 展开 关键词: Chronic spontaneous urticaria New treatment targets Pathogenesis Targeted treatment Future treatments ...
New treatments for chronic urticaria Chronic urticaria (CU) is a common, heterogeneous and debilitating disease. Antihistamines and omalizumab are the mainstay therapies of CU. Additional trea... P Kolkhir,MD Sabine Altrichter,M Munoz,... - 《Annals of Allergy, Asthma & Immunology》 被引量: ...
With the discovery and introduction of new MTT agents, the treatment for a wide variety of cancers has been revolutionized. As these treatments become increasingly recognized as therapeutic options, physicians who interpret imaging studies should be aware of different patterns of response and possible ...
Chronic urticaria (CU) involves release of histamine from mast cells and/or basophils, which in turn promotes the classic inflammatory cascade. The resultant symptoms can severely impact sufferers' quality of life and in severe cases prevent them from leading a normal existence, with c...
NEXLIZET and NEXLETOL are contraindicated in patients with a prior hypersensitivity to bempedoic acid or ezetimibe or any of the excipients. Serious hypersensitivity reactions including anaphylaxis, angioedema, rash, and urticaria have been reported. ...
upper respiratory tract, habitual miscarriage, infertility, diagnosis and treatment of chronic urticaria, atopic dermatitis, eczema, contact dermatitis, seasonal allergic respiratory diseases, bronchial asthma, treatment of allergic diseases in pregnant women, development of new treatments for allergic diseases...
Consider the potential for drug interactions prior to and during PAXLOVID therapy; review concomitant medications during PAXLOVID therapy and monitor for the adverse reactions associated with the concomitant medications. Hypersensitivity reactions have been reported with PAXLOVID including urt...
January 16 - Allakos:Allakos' decision to ax its lead asset came at the cost of substantial human capital, with the biotech laying off half its staff. The final nails in the coffin for lirentelimab were two midstage failures in patients with eczema and chronic spontaneo...
A number of treatments can induce hair regrowth in alopecia areata but do not change the course of the disease. Treatment is more effective in patchy alopecia areata than in alopecia totalis/alopecia universalis. Therapy for alopecia areata should be tailored in light of severity of the condition...